Publications by authors named "Matthew D Thompson"

Claim this Profile
R
Response to the commentary by Melidis et al. on "Untargeted CUT&Tag reads are enriched at accessible chromatin and restrict identification of potential G4-forming sequences in G4-targeted CUT&Tag experiments".
Alicia K Byrd, Matthew D Thompson

Nucleic Acids Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Untargeted CUT&Tag reads are enriched at accessible chromatin and restrict identification of potential G4-forming sequences in G4-targeted CUT&Tag experiments.
Matthew D Thompson, Alicia K Byrd

Nucleic Acids Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare SNP in the gene interferes with RPA interaction and cellular function of HELB.
Bertha Osei, Benjamin H May, Joseph S Beard, Matthew D Thompson, Duah Alkam

NAR Mol Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Fruquintinib for the Treatment of Refractory Metastatic Colorectal Cancer.
Michael J Fusco, Sandra J Casak, Sirisha L Mushti, Joyce Cheng, Brian J Christmas, Matthew D Thompson

Clin Cancer Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic models for first-in-human dose selection of immune-activating products in oncology.
Haleh Saber, Matthew D Thompson, John K Leighton

Regul Toxicol Pharmacol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare SNP in the gene interferes with RPA interaction and cellular function of HELB.
Bertha Osei, Benjamin H May, Clara M Stiefel, Kirk L West, Maroof Khan Zafar, Matthew D Thompson

bioRxiv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Futibatinib for Unresectable Advanced or Metastatic, Chemotherapy Refractory Intrahepatic Cholangiocarcinoma with FGFR2 Fusions or Other Rearrangements.
Shruti U Gandhy, Sandra J Casak, Sirisha L Mushti, Joyce Cheng, Sriram Subramaniam, Matthew D Thompson

Clin Cancer Res· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in the approval of cancer therapies by the FDA in the twenty-first century.
Emma C Scott, Andrea C Baines, Yutao Gong, Rodney Moore, Gulsum E Pamuk, Matthew D Thompson

Nat Rev Drug Discov· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Ripretinib for Advanced Gastrointestinal Stromal Tumor.
Vaibhav Kumar, Leslie Doros, Margaret Thompson, Sirisha L Mushti, Rosane Charlab, Matthew D Thompson

Clin Cancer Res· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring helicase-catalyzed unwinding of multiple duplexes simultaneously.
Matthew D Thompson, Emory G Malone, Alicia K Byrd

Methods Enzymol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role and Regulation of Pif1 Family Helicases at the Replication Fork.
Emory G Malone, Matthew D Thompson, Alicia K Byrd

Int J Mol Sci· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A structural feature of Dda helicase which enhances displacement of streptavidin and trp repressor from DNA.
Alicia K Byrd, Emory G Malone, Lindsey Hazeslip, Maroof Khan Zafar, David K Harrison, Matthew D Thompson

Protein Sci· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-omics data integration reveals correlated regulatory features of triple negative breast cancer.
Kevin Chappell, Kanishka Manna, Charity L Washam, Stefan Graw, Duah Alkam, Matthew D Thompson

Mol Omics· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive function and adaptive skills after a one-year trial of cannabidiol (CBD) in a pediatric sample with treatment-resistant epilepsy.
Matthew D Thompson, Roy C Martin, Leslie P Grayson, Steve B Ampah, Gary Cutter

Epilepsy Behav· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An FDA analysis of clinical hold deficiencies affecting investigational new drug applications for oncology products.
Michael L Manning, Matthew D Thompson, Haleh Saber, Virginia E Maher, Joyce Z Crich

Regul Toxicol Pharmacol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms.
Dhaval Patel, Matthew D Thompson, Soumen K Manna, Kristopher W Krausz, Lisa Zhang

Clin Cancer Res· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of chemopreventive efficacy of metformin in rodent models of urinary bladder, head and neck, and colon/intestine cancer.
Matthew D Thompson, Ronald A Lubet, David L Mccormick, Margie L Clapper, Ann M Bode

Oncol Lett· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caregiver-reported religious beliefs and complementary and alternative medicine use among children admitted to an epilepsy monitoring unit.
Julia Fleming Beattie, Matthew D Thompson, Pamela H Parks, Ruth Q Jacobs, Monisha Goyal

Epilepsy Behav· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary Metabolite Risk Biomarkers of Lung Cancer: A Prospective Cohort Study.
Majda Haznadar, Qiuyin Cai, Kristopher W Krausz, Elise D Bowman, Ezra Margono, Matthew D Thompson

Cancer Epidemiol Biomarkers Prev· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuropsychological consequences of sleep disturbance in children with epilepsy.
Julia F Beattie, Sarah A Koch, Lauren B Bolden, Matthew D Thompson

Epilepsy Behav· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of metformin, buformin, and phenformin on the post-initiation stage of chemically induced mammary carcinogenesis in the rat.
Zongjian Zhu, Weiqin Jiang, Matthew D Thompson, Dimas Echeverria, John N McGinley, Henry J Thompson

Cancer Prev Res (Phila)· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of mass spectrometry-based metabolomics in identification of early noninvasive biomarkers of alcohol-induced liver disease using mouse model.
Soumen K Manna, Matthew D Thompson, Frank J Gonzalez

Adv Exp Med Biol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of effect of metformin on mammary carcinogenesis in nondiabetic rat and mouse models.
Matthew D Thompson, Clinton J Grubbs, Ann M Bode, Joel M Reid, Renee McGovern

Cancer Prev Res (Phila)· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of performance validity in the Stroop Color and Word Test in mild traumatic brain injury patients: a criterion-groups validation design.
Brian J Guise, Matthew D Thompson, Kevin W Greve, Kevin J Bianchini, Laura West

J Neuropsychol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systems pharmacokinetic and pharmacodynamic approach to identify opportunities and pitfalls in energy stress-mediated chemoprevention: the use of metformin and other biguanides.
Matthew D Thompson, Henry J Thompson

Curr Drug Targets· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis